U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07120347) titled 'Remote Sensing for ADRD-Specific Activities Identification in Older Adults' on May 22.
Brief Summary: The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and cognition, remains a global concern. In the United States, more than 6.7 million individuals aged 65 and older are living with ADRD, and projected annual healthcare costs are expected to reach $1 trillion by 2050. This underscores the nee...